Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Drug composition for treating encephaledema by taking intracellular osmotic pressure as target

A cerebral edema and drug technology, applied in the field of medicine, can solve the problems of limited effect and inaccurate curative effect, and achieve the effect of maintaining stability and treating cerebral edema.

Active Publication Date: 2018-10-16
NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There are many drugs clinically used to treat cerebral edema with complex mechanisms, but most of them have limited effects and uncertain curative effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug composition for treating encephaledema by taking intracellular osmotic pressure as target
  • Drug composition for treating encephaledema by taking intracellular osmotic pressure as target
  • Drug composition for treating encephaledema by taking intracellular osmotic pressure as target

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041]A compound pharmaceutical composition with the effect of treating cerebral edema, comprising the following raw materials in parts by weight (Mol): 100 parts of sennoside A, 2 parts of cantharidin, 30 parts of nimodipine, cinepazide maleate 7.5 copies and 50 copies of Edaravone.

[0042] A preparation method of a compound pharmaceutical composition with the effect of treating cerebral edema, comprising the following steps:

[0043] (1) Take each raw material according to the concentration ratio in the aseptic operation room, and set aside;

[0044] (2) Grinding sennoside A, cantharidin, nimodipine, and cinepazide maleate into powders and mixing uniformly at a temperature of 25-35°C to obtain mixture A;

[0045] (3) Grinding Edaravone into powder and mixing uniformly at a temperature of 30-35°C to obtain mixture B;

[0046] (4) Mix the above-mentioned mixture A and mixture B evenly, put them at a temperature of 5-15° C. and let them stand for 20-30 minutes to obtain the ...

Embodiment 2

[0051] A compound pharmaceutical composition with the effect of treating cerebral edema, comprising the following raw materials in parts by weight (Mol): 50 parts of sennoside A, 2 parts of norcantharidin, 20 parts of nimodipine, cinnamon maleate Chite 10 parts and Edaravone 10 parts.

[0052] A preparation method of a compound pharmaceutical composition with the effect of treating cerebral edema, comprising the following steps:

[0053] (1) Take each raw material according to the concentration ratio in the aseptic operation room, and set aside;

[0054] (2) Grinding sennoside A, norcantharidin, nimodipine, and cinepazide maleate into powders and mixing them uniformly at a temperature of 25-35°C to obtain mixture A;

[0055] (3) Grinding Edaravone into powder and mixing uniformly at a temperature of 30-35°C to obtain mixture B;

[0056] (4) Mix the above-mentioned mixture A and mixture B evenly, put them at a temperature of 5-15° C. and let them stand for 20-30 minutes to ob...

Embodiment 3

[0060] A compound pharmaceutical composition with the effect of treating cerebral edema, comprising the following raw materials in parts by weight (Mol): 75 parts of sennoside A, 2 parts of cantharidin, 25 parts of nifedipine, cinepazide maleate 5 parts and edaravone 15 parts.

[0061] A preparation method of a compound pharmaceutical composition with the effect of treating cerebral edema, comprising the following steps:

[0062] (1) Take each raw material according to the concentration ratio in the aseptic operation room, and set aside;

[0063] (2) Grinding sennoside A, cantharidin, nifedipine, and cinepazide maleate into powders and mixing them uniformly at a temperature of 25-35°C to obtain mixture A;

[0064] (3) Grinding Edaravone into powder and mixing uniformly at a temperature of 30-35°C to obtain mixture B;

[0065] (4) Mix the above-mentioned mixture A and mixture B evenly, put them at a temperature of 5-15° C. and let them stand for 20-30 minutes to obtain the co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a drug composition for treating encephaledema and a preparation method of the drug composition. The compound drug composition comprises the following active ingredients: sennoside A, cantharidin or a derivative of cantharidin, nimodipine or nifedipine, cinepazide maleate and edaravone. An active drug and a drug combination capable of reducing colloid osmotic pressure and crystal osmotic pressure in brain cells so as to treat the encephaledema are looked for through a cell experiment, and a novel pharmaceutical application is provided clinically.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition for treating cerebral edema and a preparation method thereof. Background technique [0002] Cerebral edema is a high-risk pathological state stimulated by exogenous or endogenous pathogenic factors, manifested by abnormal increase of fluid in the brain parenchyma, increased brain volume, and elevated intracranial pressure. The increase of intracranial pressure can lead to brain tissue ischemia and hypoxia, resulting in irreversible functional damage of nerve cells, and even brain herniation and even death. According to the mechanism of occurrence, cerebral edema is divided into 4 types: 1) vasogenic cerebral edema; 2) cytotoxic cerebral edema; 3) interstitial cerebral edema; 4) osmotic cerebral edema. If more than two mechanisms are combined at the same time, it is called mixed cerebral edema. The main mechanism of vasogenic cerebral edema is the i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/704A61K31/34A61K31/4422A61K31/496A61K31/4152A61P25/00A61P7/10
CPCA61K31/34A61K31/4152A61K31/4422A61K31/496A61K31/704A61P7/10A61P25/00
Inventor 郭军吴辉文张家瑞王雨轩陈婷婷
Owner NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com